news3 weeks ago
U.S. FDA grants precedence evaluate to Roche’s bispecific antibody Glofitamab, Health News, ET HealthWorld
Zurich: Roche introduced on Friday that the U.S. Meals and Drug Administration has granted precedence evaluate to the Swiss pharmaceutical firm’s bispecific antibody Glofitamab. Glofitamab is...
